Skip to main content
. 2017 May 12;12(5):e0177235. doi: 10.1371/journal.pone.0177235

Fig 2. Immunohistochemical staining for MYSM1 in human CRC tissues.

Fig 2

(A) Expression levels of MYSM1 in primary carcinoma (n = 30) and lymphnode metastasis tissues (n = 30)were detected (×10, 100 μm; ×40, 20 μm). (B)Expression levels of MYSM1 in primary carcinoma (n = 38) and liver metastasis tissues (n = 38) were examined (×10, 100 μm; ×40, 20 μm).